Gene · 3313
NIH grants1,948
NIH grants whose papers are about the gene, through NIH's grant-paper links.
441 to 460 of 1,948
Download this page as JSON| Grant | Title | HSPA9 papers | Newest fiscal year |
|---|---|---|---|
| T32CA078586 | Training Program in Free Radical and Radiation Biology | 1 | 2024 |
| T32CA108462 | Molecular and Cellular Mechanisms in Cancer | 1 | 2024 |
| T32ES007250 | Environmental Carcinogenesis and Mutagenesis | 1 | 2024 |
| T32GM007198 | Medical Scientist Training Program | 1 | 2024 |
| U01CA243004 | Multiscale analysis of metabolic inflammation as a driver of breast cancer | 1 | 2024 |
| U01EY034669 | Deciphering the mechanisms associated with high-risk AMD genotypes for ARMS2/HTRA1 andComplement Factor H | 1 | 2024 |
| U01HL098147 | Genomic Effects on Right Ventricular Function, Clinical Features and Outcomes in CHD | 1 | 2024 |
| UL1TR001412 | University of Buffalo Clinical and Translational Science Institute | 1 | 2024 |
| UL1TR001442 | UC San Diego Clinical and Translational Research Institute | 1 | 2024 |
| UL1TR001449 | UNM HSC Clinical and Translational Science Center | 1 | 2024 |
| ZIAAG007390 | Health, Aging and Body Composition Study | 1 | 2024 |
| ZIAHD008735 | Diagnosis, Pathophysiology And Molecular Biology of Pheochromocytoma and Paraganglioma | 1 | 2024 |
| R01ES021667 | Neuroendocrine Coordination of Mitochondrial Stress Signaling and Proteostasis | 6 | 2023 |
| P01CA114046 | Targeted Therapies in Melanoma | 3 | 2023 |
| R01CA232056 | OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADINGFOR TREATING MESOTHELIOMA | 2 | 2023 |
| R01GM089778 | Proteolytic Control of Iron Metabolism by the E3 Ubiquitin Ligase FBXL5 | 2 | 2023 |
| R01NS115903 | Proteostasis dysregulation and alpha-synuclein | 2 | 2023 |
| T32ES007032 | Environmental Pathology/Toxicology Training Program | 2 | 2023 |
| F31GM143849 | Molecular Mechanisms of FUNDC1-Mediated Mitophagy | 1 | 2023 |
| I01BX002905 | The Role of Long Noncoding RNAs in Cancer | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3313/grants?page=23